IL190014A0 - Antibodies as t cell receptor mimics, methods of production and uses thereof - Google Patents

Antibodies as t cell receptor mimics, methods of production and uses thereof

Info

Publication number
IL190014A0
IL190014A0 IL190014A IL19001408A IL190014A0 IL 190014 A0 IL190014 A0 IL 190014A0 IL 190014 A IL190014 A IL 190014A IL 19001408 A IL19001408 A IL 19001408A IL 190014 A0 IL190014 A0 IL 190014A0
Authority
IL
Israel
Prior art keywords
antibodies
production
methods
cell receptor
receptor mimics
Prior art date
Application number
IL190014A
Other languages
English (en)
Original Assignee
Jon A Weidanz
Vaughan P Wittman
Receptor Logic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jon A Weidanz, Vaughan P Wittman, Receptor Logic Ltd filed Critical Jon A Weidanz
Publication of IL190014A0 publication Critical patent/IL190014A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL190014A 2005-09-07 2008-03-06 Antibodies as t cell receptor mimics, methods of production and uses thereof IL190014A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US71462105P 2005-09-07 2005-09-07
US75154205P 2005-12-19 2005-12-19
US75273705P 2005-12-20 2005-12-20
US83827606P 2006-08-17 2006-08-17
PCT/US2006/034547 WO2007030451A2 (fr) 2005-09-07 2006-09-07 Anticorps utilises comme mimetiques de recepteurs de lymphocytes t, leurs methodes de production et leurs applications

Publications (1)

Publication Number Publication Date
IL190014A0 true IL190014A0 (en) 2008-08-07

Family

ID=37836380

Family Applications (1)

Application Number Title Priority Date Filing Date
IL190014A IL190014A0 (en) 2005-09-07 2008-03-06 Antibodies as t cell receptor mimics, methods of production and uses thereof

Country Status (5)

Country Link
EP (1) EP1933864A4 (fr)
AU (1) AU2006289683A1 (fr)
CA (1) CA2662798A1 (fr)
IL (1) IL190014A0 (fr)
WO (1) WO2007030451A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2026837A4 (fr) * 2006-06-01 2010-06-02 Receptor Logic Inc Anticorps utiles en tant qu'analogues de récepteur des lymphocytes t, leurs procédés de production et leurs utilisations
EP2262834A4 (fr) * 2008-02-27 2011-08-17 Receptor Logic Inc Anticorps imitant les récepteurs des lymphocytes t, leurs procédés de production et d utilisation
UA114108C2 (uk) 2012-07-10 2017-04-25 Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69326064T2 (de) * 1992-05-26 2000-05-25 Rijksuniversiteit Te Leiden Le Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
US20040191260A1 (en) * 2003-03-26 2004-09-30 Technion Research & Development Foundation Ltd. Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
WO2002014870A2 (fr) * 2000-08-14 2002-02-21 Akzo Nobel N.V. Utilisation d'anticorps contre des complexes de peptides mhc specifiques
WO2002046416A2 (fr) * 2000-12-04 2002-06-13 Argonex Pharmaceuticals Immunogenes induisant une reponse des lymphocytes t cytotoxiques pour la prevention, le traitement et le diagnostic de cancers
WO2003070752A2 (fr) * 2002-02-20 2003-08-28 Dyax Corporation Ligands de liaison au complexe mhc-peptide
FR2839452A1 (fr) * 2002-05-07 2003-11-14 Pf Medicament Utilisation de peptide derive de la sous-unite beta de l'hcg pour generer une reponse de type ctl antitumorale
EP1625151A2 (fr) * 2003-05-13 2006-02-15 The Board Of Regents Of The University Of Oklahoma Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh
AU2005247950B2 (en) * 2004-05-27 2012-02-02 Receptor Logic, Inc. Antibodies as T cell receptor mimics, methods of production and uses thereof

Also Published As

Publication number Publication date
WO2007030451A3 (fr) 2009-04-16
AU2006289683A1 (en) 2007-03-15
EP1933864A4 (fr) 2009-12-16
WO2007030451A2 (fr) 2007-03-15
CA2662798A1 (fr) 2007-03-15
EP1933864A2 (fr) 2008-06-25

Similar Documents

Publication Publication Date Title
IL179427A0 (en) Antibodies as t cell receptor mimics, methods of production and uses thereof
IL195470A0 (en) Antibodies as t cell receptor mimics, methods of production and uses thereof
HRP20190220T1 (hr) Anti-il-23 protutijela, pripravci, postupci i upotrebe
HUS1800021I1 (hu) Humán anti-Il-23 ellenanyagok, készítmények, eljárások és alkalmazások
HK1248523A1 (zh) 用電穿孔向細胞負載抗原
IL190472A (en) Glyphican Antibody 3 Methods for their preparation and use
EP1857126A4 (fr) Feuille de cellules cultivees, son procede de production et son procede d application
EP1988152A4 (fr) Construction pour la culture cellulaire, contenant pour la culture cellulaire, construction ayant un sphéroïde, contenant ayant un sphéroïde et procédé de production correspondant
HUE037580T2 (hu) Eszközök és eljárások ellenanyag-termelõ sejtek stabilitásának befolyásolására
EP1743025A4 (fr) Techniques de production de lymphocytes t regulateurs et utilisation de ceux-ci
DE602006006377D1 (de) Brennstoffzellenseparator und seine Herstellungsmethode
EP2262834A4 (fr) Anticorps imitant les récepteurs des lymphocytes t, leurs procédés de production et d utilisation
IL190014A0 (en) Antibodies as t cell receptor mimics, methods of production and uses thereof
GB0600991D0 (en) Assays, antibodies and uses thereof
GB0508701D0 (en) Assays, antibodies and uses thereof
GB0521718D0 (en) Assays, antibodies and uses thereof